Role of extracellular vesicles in chronic lung disease
- PMID: 33712504
- PMCID: PMC8461402
- DOI: 10.1136/thoraxjnl-2020-216370
Role of extracellular vesicles in chronic lung disease
Abstract
To explore the role of extracellular vesicles (EVs) in chronic lung diseases.EVs are emerging as mediators of intercellular communication and possible diagnostic markers of disease. EVs harbour cargo molecules including RNA, lipids and proteins that they transfer to recipient cells. EVs are intercellular communicators within the lung microenvironment. Due to their disease-specific cargoes, EVs have the promise to be all-in-one complex multimodal biomarkers. EVs also have potential as drug carriers in chronic lung disease.Descriptive discussion of key studies of EVs as contributors to disease pathology, as biomarkers and as potential therapies with a focus on chronic obstructive pulmonary disorder (COPD), cystic fibrosis (CF), asthma, idiopathic pulmonary fibrosis and lung cancer.We provide a broad overview of the roles of EV in chronic respiratory disease. Recent advances in profiling EVs have shown their potential as biomarker candidates. Further studies have provided insight into their disease pathology, particularly in inflammatory processes across a spectrum of lung diseases. EVs are on the horizon as new modes of drug delivery and as therapies themselves in cell-based therapeutics.EVs are relatively untapped sources of information in the clinic that can help further detail the full translational nature of chronic lung disorders.
Keywords: COPD exacerbations; asthma; cystic fibrosis; idiopathic pulmonary fibrosis; lung cancer.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures

Similar articles
-
Extracellular vesicles in chronic obstructive pulmonary disease (COPD).J Thorac Dis. 2019 Oct;11(Suppl 17):S2141-S2154. doi: 10.21037/jtd.2019.10.16. J Thorac Dis. 2019. PMID: 31737342 Free PMC article. Review.
-
Extracellular vesicles: novel communicators in lung diseases.Respir Res. 2020 Jul 8;21(1):175. doi: 10.1186/s12931-020-01423-y. Respir Res. 2020. PMID: 32641036 Free PMC article. Review.
-
Decoding the role of extracellular vesicles in pathogenesis of cystic fibrosis.Mol Cell Pediatr. 2025 Apr 21;12(1):5. doi: 10.1186/s40348-025-00190-4. Mol Cell Pediatr. 2025. PMID: 40257719 Free PMC article. Review.
-
Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis.Am J Respir Crit Care Med. 2018 Dec 15;198(12):1527-1538. doi: 10.1164/rccm.201708-1580OC. Am J Respir Crit Care Med. 2018. PMID: 30044642
-
Lung mesenchymal stem cells-derived extracellular vesicles attenuate the inflammatory profile of Cystic Fibrosis epithelial cells.Cell Signal. 2018 Nov;51:110-118. doi: 10.1016/j.cellsig.2018.07.015. Epub 2018 Aug 1. Cell Signal. 2018. PMID: 30076968
Cited by
-
Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Pathogenesis, Biomarkers and Innovative Therapeutic Strategies.Int J Nanomedicine. 2024 Nov 25;19:12593-12614. doi: 10.2147/IJN.S491335. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39619058 Free PMC article. Review.
-
Wildfire-relevant woodsmoke and extracellular vesicles (EVs): Alterations in EV proteomic signatures involved in extracellular matrix degradation and tissue injury in airway organotypic models.Environ Res. 2025 Jan 1;264(Pt 2):120395. doi: 10.1016/j.envres.2024.120395. Epub 2024 Nov 19. Environ Res. 2025. PMID: 39571711
-
Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis.J Pers Med. 2024 Jan 13;14(1):93. doi: 10.3390/jpm14010093. J Pers Med. 2024. PMID: 38248793 Free PMC article. Review.
-
Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.J Intensive Care. 2023 Aug 3;11(1):35. doi: 10.1186/s40560-023-00683-2. J Intensive Care. 2023. PMID: 37537685 Free PMC article.
-
Extracellular vesicle-encapsulated microRNA signatures of cigarette smoking and smoking-related harm.Respir Med. 2025 Sep;246:108226. doi: 10.1016/j.rmed.2025.108226. Epub 2025 Jun 28. Respir Med. 2025. PMID: 40588139
References
-
- Howell WH. The nature and action of the thromboplastic (ZYMOPLASTIC) substance of the tissues. Am J Physiol 1912;31:1–21. 10.1152/ajplegacy.1912.31.1.1 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical